Circio Holding ASA (LTS:0RIS) Current Deferred Taxes Liabilities: kr Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RIS Circio Holding ASA LTS:0RIS
17 GF Score
Price kr11.82
! 4 Warning Signs
View Full Analysis

What is Circio Holding ASA Current Deferred Taxes Liabilities?

Circio Holding ASA LTS:0RIS +1.03% 17 Current Deferred Taxes Liabilities is kr Mil as of Jun. 2026. GuruFocus rates LTS:0RIS with a GF Score™ of 17/100. The stock has 4 warning signs investors should review.

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Circio Holding ASA's current deferred tax liabilities for the quarter that ended in Jun. 2026 was kr Mil.

Circio Holding ASA Current Deferred Taxes Liabilities Related Terms

Circio Holding ASA Current Deferred Taxes Liabilities Historical Data

* Premium members only.

The historical data trend for Circio Holding ASA's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Circio Holding ASA Current Deferred Taxes Liabilities Chart

Circio Holding ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Taxes Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Circio Holding ASA Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Current Deferred Taxes Liabilities Get a 7-Day Free Trial - - - - -
LTS:0RIS
17GF Score
Circio Holding ASA LTS:0RIS
Current Deferred Taxes Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Taxes Liabilities of kr Mil mean?
Circio Holding ASA (LTS:0RIS) has a Current Deferred Taxes Liabilities of kr Mil as of Jun. 2026. Current Deferred Tax Liabilities records the total amount of taxes due for the period but not yet paid. View historical data on Circio Holding ASA and its competitors.
Is Circio Holding ASA's Current Deferred Taxes Liabilities too high?
Circio Holding ASA's current Current Deferred Taxes Liabilities is kr Mil. Overall, Circio Holding ASA has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Circio Holding ASA's Current Deferred Taxes Liabilities compare to VRTX and REGN?
Circio Holding ASA's Current Deferred Taxes Liabilities of kr Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Taxes Liabilities for a Biotechnology company?
A good Current Deferred Taxes Liabilities depends on the Biotechnology industry context. However, Current Deferred Taxes Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Taxes Liabilities mean?
A high Current Deferred Taxes Liabilities can signal that a stock is expensive relative to its fundamentals. Current Deferred Tax Liabilities records the total amount of taxes due for the period but not yet paid. View historical data on Circio Holding ASA and its competitors. Circio Holding ASA's current Current Deferred Taxes Liabilities is kr Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Circio Holding ASA stock overvalued right now?
Circio Holding ASA (LTS:0RIS) has a current Current Deferred Taxes Liabilities of kr Mil. The current Current Deferred Taxes Liabilities is kr Mil. Circio Holding ASA's overall GF Score™ is 17/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Taxes Liabilities calculated?
Current Deferred Taxes Liabilities is calculated from a company's financial statements. For Circio Holding ASA (LTS:0RIS), the current Current Deferred Taxes Liabilities is kr Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Circio Holding ASA Business Description

Other Exchanges CRNA:NorwayTA50:Germany
Address c/o Mesh Community AS, Tordenskiolds Gate 2, Oslo, NOR, 0160
Circio Holding ASA is a biotechnology company developing circular RNA expression technology for gene and cell therapy applications. It has developed a circular RNA (circRNA) vector expression platform known as circVec, which is based on modular genetic constructs designed for circRNA production within target cells. The platform is being developed for applications including genetic medicine, cell therapy, and chronic disease treatment. The company's activities also include the development of RNA, DNA, and viral therapeutic technologies related to gene expression and protein production.
17GF Score

Get the complete analysis for LTS:0RIS

Current Deferred Taxes Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr11.82
Price